Population
Small molecules evaluated for HERG cardiac potassium channel blockade
Design
Preclinical
Authors
Loading...
May aid early hERG liability screening in drug development; leaves open clinical translation pending prospective validation.
Genetic programming using molecular fragment-based descriptors can accurately predict HERG channel blockade, providing a robust tool for early drug safety screening.
Bains et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: